Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka

Table 1 The population samples interviewed in eight districts (IUs) with a comparison of the observed and reported drug coverage in the independent evaluation of the July 2003 national MDA.

			Population sample interviewed
Province	District (IU)	District Population (Millions)†	No of people	% District Population	% Observed drug coverage	% Reported drug coverage*	P value
Southern	Hambantota	0.53	490	0.09	96.3	93.0	0.30
	Matara	0.76	478	0.06	81.8	87.0	0.31
	Galle	0.99	470	0.05	80.2	83.0	0.61
Western	Kalutara	1.06	497	0.05	91.8	89.0	0.50
	Colombo	1.86	475	0.03	64.4	88.7	P < 0.001
	Gampaha	2.07	510	0.02	70.6	84.5	0.02
North Western	Kurunegala	1.45	477	0.03	89.5	82.0	0.13
	Puttalam	0.71	478	0.07	94.8	85.0	0.02
Colombo Municipality		0.38	483	0.13	46.6	88.7	P < 0.001
Total		9.80	4358	0.04	79.6	86.8	0.17

† Census of Population and Housing-2001, Department of Census and Statistics, Government of Sri Lanka, 2003.
* Source: Courtesy Programme Manager, National PELF.